Immunogen reported $-62021000 in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Astellas Pharma 4503:JP Y 31679M 42195M
AstraZeneca AZN:LN 258259.83M 36783.7M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Exelixis EXEL:US $ 88.51M 3.28M
Halozyme Therapeutics HALO:US $ 30.01M 51.62M
Immunogen IMGN:US $ -62.02M 37.88M
Intrexon XON:US $ -26.15M 6.84M
Karyopharm Therapeutics KPTI:US $ -48941000 7.67M
Macrogenics MGNX:US $ -41.3M 25.14M
Nektar Therapeutics NKTR:US $ -158.97M 68.7M
Novartis NVS:US $ 4129M 217M